Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval (Q36237951)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval
scientific article

    Statements

    Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval (English)
    1 August 2005
    5928-5934

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit